The current valuation score of Senti Biosciences Inc is 6.41, ranking 328 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.73, which is -108.54% below the recent high of 0.06 and -114.69% above the recent low of -1.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.